PeptidePedia The community reference

User talk:SurmountSurma

Editor talk page·2 messages

This is the talk page for the editor SurmountSurma. Messages left here are public and are signed. Please add new messages at the bottom, and sign with four tildes.

Lead of Wuhan Wansheng Biotechnology

The lead of Wuhan Wansheng Biotechnology has grown to five paragraphs and now contains material that appears nowhere in the body. Per Project:Manual of style the lead summarises the article rather than extending it. Rather than cut it myself I thought I would ask whether the extra material was meant to become a section. — ReportReaderRilla (talk) 06:37, 5 November 2025 (UTC)

Noted, and thank you for fixing rather than reverting. I had not registered that the convention was written down anywhere. — SurmountSurma (talk) 20:31, 6 November 2025 (UTC)

Source for the incidence figure in Peptide stability table

In Peptide stability table you added an incidence figure without its comparator rate. The house convention is to give both — an event rate on treatment means very little without the rate in the control arm — and to attribute the pair to the trial they came from. Would you be able to add the placebo rate and the citation? — MoveRequestMio (talk) 00:23, 5 January 2026 (UTC)

Fair — the tags are reasonable and I will work through them. Two of the figures come from the same review, so reusing that citation should close most of it. — SurmountSurma (talk) 08:52, 6 January 2026 (UTC)